multispecific Anticalin program (Sanofi)

N/A

Report date: 2025/03/20 14:56:14

Base Information

Drug Namemultispecific Anticalin program (Sanofi)
Drug Alias Namemultispecific Anticalin program (Pieris/Sanofi)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPieris Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesPieris Pharmaceuticals Inc
Active IndicationsCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A